Eyenovia Inc (EYEN) Regains Nasdaq Compliance

Go back to Eyenovia Inc (EYEN) Regains Nasdaq Compliance

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

February 26, 2025 7:00 AM EST

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (Eyenovia or the Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet® device, today announced that it has been informed by staff of The Nasdaq Stock Market LLC that the Company has regained compliance with all Nasdaq Capital Market continued listing requirements, including Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement rule, and Listing Rule 5810(c)(3)(A)(iii), the low priced stocks rule.

Maintaining our Nasdaq listing, along with other steps we have taken to restructure... More